Economics and health experts discuss the prolonged opioid crisis, examining economics' role in healthcare policy. They explore the history of opioids, social connections' impact on addiction spread, and unintended consequences of drug decriminalization. Strategies to combat drug abuse include disrupting drug markets and investing in prevention.

Professionals discuss the effectiveness of $55 billion in combating the opioid epidemic, touching on prevention, treatment, and distribution of funds. They explore the challenges of addiction, stigma, and the impact of fentanyl. The episode also compares the opioid crisis to the HIV/AIDS epidemic, emphasizing the importance of diverse input in policy-making.

Stanford professor Keith Humphreys shares his insights on drug decriminalization, revealing the grim realities faced by Oregon, San Francisco, and Seattle. He discusses the surge in overdose deaths as a result of these policies, highlighting the urgent need for supportive services. Humphreys also delves into the political fallout for district attorneys who backed these measures and the varied public opinions on drug reform. Additionally, he addresses the challenges of urban development initiatives in New York City.

Experts Gail D’Onofrio and Keith Humphreys discuss opioid addiction treatment challenges, innovations, and the benefits of buprenorphine. They explore the bio-social factors of addiction, peer counselors in recovery, and updates in addiction medicine. The podcast navigates harm reduction, stigma, and financial advice in opioid addiction recovery.

Keith Humphreys, a Stanford psychiatry professor focused on addiction, joins Shrita Walden, the executive director of the Kentucky Harm Reduction Coalition. They discuss the unprecedented 15% drop in U.S. overdose deaths, citing improved access to treatment and education. The conversation highlights the importance of localized strategies to address disparities, especially in marginalized communities. They also delve into the shifting drug landscape and the need for sustained harm reduction efforts to address the ongoing opioid crisis.